High Titer and Yield
ACC overexpression and pathway blocking eliminate bottlenecks and competition, resulting in significantly higher yields than plant extraction or chemical synthesis.
Resveratrol is a high-value polyphenol used extensively in cosmetics and supplements for its powerful antioxidant and anti-aging properties. Industrial production has traditionally relied on natural plant extraction (e.g., from Japanese knotweed), which results in Low yield and high cost and suffers from variability and environmental impact. Chemical synthesis is complex , yields mixed and often less active isomers (cis/trans), and is environmentally unfriendly . These issues necessitate a stable, high-yield biosynthetic route. The primary biosynthetic challenge is the Insufficient supply of the limiting precursor Malonyl-CoA in the host cell, which is essential for the Resveratrol pathway but is rapidly consumed by native competing pathways.
CD Biosynsis offers a comprehensive synthetic biology and metabolic engineering solution, typically using engineered yeast (S. cerevisiae) or bacteria (E. coli) as hosts. To establish the Resveratrol pathway, we Introduce plant genes into the host, specifically the Phenylpropanoid Pathway genes like 4-Coumarate-CoA Ligase (4CL) and Stilbene Synthase (STS) , which are necessary for converting p-coumaric acid (or tyrosine) into Resveratrol. To overcome the limiting precursor supply, we Overexpress key enzymes like Acetyl-CoA Carboxylase (ACC) to efficiently convert Acetyl-CoA into the required Malonyl-CoA, significantly boosting Resveratrol flux. Finally, to maximize carbon efficiency and purity, we Block competing pathways that synthesize fatty acids or flavonoids , preventing Malonyl-CoA from being diverted and ensuring high Resveratrol yield and high purity of the active trans-Resveratrol isomer.
Get a QuoteDeveloping a cost-effective, high-quality Resveratrol product faces these key challenges:
A successful solution must ensure robust Malonyl-CoA supply and eliminate product competition.
CD Biosynsis utilizes advanced metabolic engineering and synthetic biology to optimize Resveratrol production:
Introduce Plant Genes (4CL, STS) into Engineered Hosts
We integrate and optimize the 4CL and STS genes from high-activity sources (e.g., Vitis vinifera) to establish the Resveratrol biosynthesis route in the host.
Overexpress Acetyl-CoA Carboxylase (ACC) to Boost Malonyl-CoA Supply
We highly overexpress ACC, the rate-limiting enzyme converting Acetyl-CoA to Malonyl-CoA, resolving the Insufficient supply of Malonyl-CoA bottleneck.
Block Competing Pathways (Fatty Acids, Flavonoids)
We use gene knockouts (e.g., FAS genes, CHS genes) to prevent the diversion of Malonyl-CoA and p-coumaroyl-CoA, maximizing flux to Resveratrol.
Subcellular Compartmentalization and Scaffolding
We use protein scaffolds to physically link 4CL and STS, improving the channeling of intermediates and overall conversion efficiency.
This integrated approach ensures high supply of both precursors and directs the flow towards high-purity Resveratrol product.
Our Resveratrol engineering service is dedicated to pursuing the following production goals:
High Titer and Yield
ACC overexpression and pathway blocking eliminate bottlenecks and competition, resulting in significantly higher yields than plant extraction or chemical synthesis.
High Trans-Isomer Purity
Enzymatic synthesis using STS ensures the preferential and highly selective production of the active trans-Resveratrol isomer , avoiding the mixed isomers from chemical routes.
Cost-Effective and Sustainable Production Icon
Microbial fermentation using glucose as a carbon source is more cost-effective and environmentally friendly than complex plant extraction or chemical synthesis. [Image of Cost Reduction Icon]
Consistent Supply Chain Icon
Production is independent of climate, harvesting seasons, and geographical location, providing a reliable source.
Tunable Pathway Icon
The biosynthetic pathway can be tuned to produce specific Resveratrol derivatives (e.g., piceid) for targeted applications.
We provide a superior and sustainable manufacturing platform for trans-Resveratrol.
Our Resveratrol strain engineering service follows a rigorous, multi-stage research workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and product quality attributes.
Explore the potential for a high-titer, high-purity Resveratrol supply. CD Biosynsis provides customized strain and process engineering solutions:
Why is Malonyl-CoA supply the limiting factor?
Malonyl-CoA is a key intermediate in the biosynthesis of fatty acids, which are vital for cell membranes. Since the Resveratrol pathway requires three Malonyl-CoA units per product molecule , its highly active consumption by native fatty acid synthases makes it the most critical bottleneck for high Resveratrol yield, leading to the Insufficient supply challenge .
How does ACC overexpression solve the supply bottleneck?
Acetyl-CoA Carboxylase (ACC) catalyzes the conversion of Acetyl-CoA to Malonyl-CoA. By overexpressing a highly active ACC variant, we significantly increase the rate of Malonyl-CoA generation , pushing the metabolic flux towards Resveratrol production.
What is the benefit of Blocking Competing Pathways ?
Blocking pathways like fatty acid synthesis (FAS) is necessary to prevent Malonyl-CoA consumption by native cellular processes. Blocking flavonoid synthesis prevents the diversion of the p-coumaroyl-CoA precursor, ensuring maximum carbon efficiency towards Resveratrol.
Why is trans-Resveratrol purity important?
Trans-Resveratrol is the naturally occurring and most biologically active isomer . Chemical synthesis yields both trans-and cis-isomers, which must be separated. Microbial synthesis using the STS enzyme specifically produces the trans form, greatly simplifying purification and ensuring high quality for pharmaceutical and cosmetic use.
What is the estimated project timeline?
A project involving multi-gene pathway integration, ACC overexpression, and multiple gene knockouts typically requires 22-28 weeks for final strain delivery and performance validation.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.